MAdCAM-1 expression is increased at sites of intestinal inflammation, and MAdCAM-1 is also expressed at extra-intestinal sites that can be affected in patients with IBD, such as the joints, eyes, and skin [77]. Here, MADCAM1 is linked to inflammatory bowel disease.